CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Up 15.9% in May

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCYGet Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 13,100 shares, a growth of 15.9% from the May 15th total of 11,300 shares. Based on an average daily volume of 29,700 shares, the short-interest ratio is currently 0.4 days.

CSPC Pharmaceutical Group Trading Down 1.2 %

CSPCY traded down C$0.04 during trading on Monday, hitting C$3.38. 3,733 shares of the stock were exchanged, compared to its average volume of 25,571. The firm has a 50 day simple moving average of C$3.29 and a 200 day simple moving average of C$3.25. CSPC Pharmaceutical Group has a 1 year low of C$2.63 and a 1 year high of C$3.71.

CSPC Pharmaceutical Group Increases Dividend

The firm also recently announced a dividend, which will be paid on Thursday, July 11th. Shareholders of record on Monday, June 3rd will be issued a dividend of $0.0573 per share. This is a boost from CSPC Pharmaceutical Group’s previous dividend of $0.06. The ex-dividend date is Friday, May 31st.

CSPC Pharmaceutical Group Company Profile

(Get Free Report)

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.

See Also

Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.